StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.49−0.01 (-0.67%)

Close on Nov 13, 2026Market cap $37.96MP/E –Yield –

BioRestorative Therapies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BioRestorative Therapies's enterprise value was $36.15M on Nov 11, 2026, against $167.63M a year earlier. Over the last 5 years it ranged from $32.09M to $379.46M, with a median of $198.66M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$36.15M-80.2%
2025Dec 31, 2025$183.00M-1.0%
2024Dec 31, 2024$184.82M+23.1%
2023Dec 29, 2023$150.19M-18.4%
2022Dec 30, 2022$184.07M+129.5%
2021Dec 31, 2021$80.22M-63.5%
2020Dec 31, 2020$219.89M+8946.5%
2019Dec 31, 2019$2.43M-98.5%
2018Dec 31, 2018$158.05M-61.9%
2017Dec 29, 2017$414.76M+41.4%
2016Dec 30, 2016$293.26M+20.6%
2015Dec 31, 2015$243.17M+1610.4%
2014Dec 31, 2014$14.22M+66.1%
2013Dec 31, 2013$8.56M+2672.4%
2012Dec 27, 2012$308.74K+43.1%
2011Dec 30, 2011$215.78K–

More BioRestorative Therapies figures

See a number that looks wrong?